I'll post much more on my recently released study on subsidies to nuclear power over the next few days. However, I wanted to take a momentary break from the world of natural resource subsidies to congratulate my friend Eric Olson and Vertex Pharmaceuticals on the success of their phase 3 trials for a new treatment for cystic fibrosis. It has been a long time coming, and is positive news for a disease that rarely has any.
UPDATE: Here's a good history of the collaboration that led to this success.
